Ex Parte WAGNER et al - Page 3


                 Appeal No.  2003-1126                                                       Page 3                   
                 Application No.  08/444,285                                                                          

                                      therewith, thereby obtaining a genetically transformed                          
                                      zygote;                                                                         
                                             (ii) transplanting an embryo from the genetically                        
                                      transformed zygote into a psuedopregnant female; and                            
                                             (iii) allowing the embryo to develop to term; where                      
                                      said gene and control sequence are selected so that the                         
                                      gene is not activated in such a manner and degree as would                      
                                      prevent normal development of the embryo to term; and said                      
                                      polypeptide or protein is producible in a cell of said mammal                   
                                      which bears said gene, as a result of the expression of said                    
                                      gene under the control of said control sequence, and where                      
                                      said mammal, absent said exogenous genetic material is                          
                                      unable to produce said polypeptide or protein; and                              
                                      (b) expressing said gene in said mammal, or progeny thereof                     
                               which retain said gene in expressible form, thereby producing said                     
                               polypeptide or protein at a detectable level, where said mammal is                     
                               selected from the group consisting of rodents, rabbits, goats, pigs,                   
                               cattle, and sheep.                                                                     

                        The examiner relies upon the following references:                                            
                 Strojek et al. (Strojek), “The use of transgenic animal techniques for livestock                     
                 improvement,” Genetic Engineering:  Principles and methods, Vol. 10,                                 
                 pp. 221-246 (1988)                                                                                   
                 Kappel et al. (Kappel), “Regulating gene expression in transgenic animals,”                          
                 Current Opinion in Biotechnology, Vol. 3, pp. 548-553 (1992)                                         
                 Houdebine, “Production of pharmaceutical proteins from transgenic animals,”                          
                 Journal of Biotechnology, Vol. 34, pp. 269-287 (1994)                                                
                 Wall, “Transgenic livestock:  Progress and prospects for the future,”                                
                 Theriogenology, Vol. 45, pp. 57-68 (1996)                                                            
                        Claims 39, 41, 43, 45, 50, 51, 55-79, 82, 83, 86-114, 116 and 119 stand                       
                 rejected under the judicially created obviousness-type double-patenting as being                     
                 unpatentable over claims 1-7 of U.S. Patent No. 4,873,191.  Claims 39, 41, 43,                       
                 45, 50, 51, 55-79, 82, 83, 86-114, 116 and 119 also stand rejected under 35                          
                 U.S.C. § 112, first paragraph, on the grounds that the specification fails to enable                 






Page:  Previous  1  2  3  4  5  6  7  8  9  10  11  12  13  14  Next 

Last modified: November 3, 2007